| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Marco Onofrj, Astrid Thomas, Pietro Tiraboschi, Gregor Wenning, Francesco Gambi, Gianna Sepede, Massimo Di Giannantonio, Caterina Di Carmine, Daniela Monaco, Valerio Maruotti, Fausta Ciccocioppo, Maria Chiara D'Amico, Laura Bonann. Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. Journal of the neurological sciences. vol 310. issue 1-2. 2012-02-16. PMID:21813140. |
somatoform disorders (sfmd) were recently described in parkinson disease (pd) and dementia with lewy bodies (dlb). |
2012-02-16 |
2023-08-12 |
human |
| Marco Onofrj, Astrid Thomas, Pietro Tiraboschi, Gregor Wenning, Francesco Gambi, Gianna Sepede, Massimo Di Giannantonio, Caterina Di Carmine, Daniela Monaco, Valerio Maruotti, Fausta Ciccocioppo, Maria Chiara D'Amico, Laura Bonann. Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. Journal of the neurological sciences. vol 310. issue 1-2. 2012-02-16. PMID:21813140. |
after 2-9 years of follow up, 488 patients were labelled as pd, 415 as alzheimer disease, 162 as dlb, 48 as progressive supranuclear palsy, 48 as multiple system atrophy and 49 as fronto-temporal dementia. |
2012-02-16 |
2023-08-12 |
human |
| Markus Weih, Umüt Degirmenci, Sebastian Kreil, Gerald Suttner, Daniela Schmidt, Johannes Kornhuber, Piotr Lewczuk, Torsten Kuwer. Nuclear medicine diagnostic techniques in the era of pathophysiology-based CSF biomarkers for Alzheimer's disease. Journal of Alzheimer's disease : JAD. vol 26 Suppl 3. 2012-02-09. PMID:21971454. |
numerous studies have shown the diagnostic value of reduced cbf and metabolic changes using perfusion-spect and fdg-pet in ad diagnosis as well as in differential diagnosis against frontotemporal dementia (ftd), dementia with lewy-bodies (dlb), and vascular cognitive disorders. |
2012-02-09 |
2023-08-12 |
Not clear |
| Zuzana Walker, Joanne Rodd. Dopaminergic imaging: clinical utility now and in the future. International psychogeriatrics. vol 23 Suppl 2. 2012-02-02. PMID:21843378. |
abnormalities in dopaminergic imaging measures are consistent features of dementia with lewy bodies (dlb) and other parkinsonian syndromes, and can be used to facilitate diagnosis, particularly in distinguishing between dlb and alzheimer's disease. |
2012-02-02 |
2023-08-12 |
Not clear |
| Michael J Firbank, Andrew M Blamire, Andrew Teodorczuk, Emma Teper, Emma J Burton, Dipayan Mitra, John T O'Brie. High resolution imaging of the medial temporal lobe in Alzheimer's disease and dementia with Lewy bodies. Journal of Alzheimer's disease : JAD. vol 21. issue 4. 2012-01-31. PMID:21504120. |
we used high resolution (0.3 mm in-plane) coronal 3t magnetic resonance (mr) imaging of the medial temporal lobe in 16 subjects with alzheimer's disease (ad), 16 with dementia with lewy bodies (dlb), and 16 similarly aged healthy subjects. |
2012-01-31 |
2023-08-12 |
human |
| Annika Ohrfelt, Henrik Zetterberg, Kerstin Andersson, Rita Persson, Dzemila Secic, Gunnar Brinkmalm, Anders Wallin, Ezra Mulugeta, Paul T Francis, Eugeen Vanmechelen, Dag Aarsland, Clive Ballard, Kaj Blennow, Ann Westman-Brinkmal. Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method. Neurochemical research. vol 36. issue 11. 2012-01-27. PMID:21674238. |
parkinson's disease (pd) and dementia with lewy bodies (dlb) are neurodegenerative diseases that are characterized by intra-neuronal inclusions of lewy bodies in distinct brain regions. |
2012-01-27 |
2023-08-12 |
human |
| Annika Ohrfelt, Henrik Zetterberg, Kerstin Andersson, Rita Persson, Dzemila Secic, Gunnar Brinkmalm, Anders Wallin, Ezra Mulugeta, Paul T Francis, Eugeen Vanmechelen, Dag Aarsland, Clive Ballard, Kaj Blennow, Ann Westman-Brinkmal. Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method. Neurochemical research. vol 36. issue 11. 2012-01-27. PMID:21674238. |
the different forms of α-syn were further studied by western blotting in brain tissue homogenates from the temporal cortex brodmann area 36 (ba36) and the dorsolateral prefrontal cortex ba9 derived from controls, patients with dlb and pd with dementia (pdd). |
2012-01-27 |
2023-08-12 |
human |
| R E J Musgrove, A E King, T C Dickso. Neuroprotective upregulation of endogenous α-synuclein precedes ubiquitination in cultured dopaminergic neurons. Neurotoxicity research. vol 19. issue 4. 2012-01-20. PMID:20617407. |
α-synuclein is the major protein component of lewy bodies--the pathological hallmark of parkinson's disease (pd) and dementia with lewy bodies (dlb). |
2012-01-20 |
2023-08-12 |
Not clear |
| Walter Maetzler, Daniela Berg, Matthis Synofzik, Kathrin Brockmann, Jana Godau, Arthur Melms, Thomas Gasser, Stephanie Hörnig, Markus Langkam. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias. Journal of Alzheimer's disease : JAD. vol 26. issue 1. 2012-01-10. PMID:21593566. |
there is increasing evidence that in lewy body-associated dementias (encompassing parkinson's disease with dementia (pdd) and dementia with lewy bodies (dlb)), the adaptive immune system is altered and the degenerative process includes glial cells in addition to neuronal structures. |
2012-01-10 |
2023-08-12 |
human |
| Walter Maetzler, Daniela Berg, Matthis Synofzik, Kathrin Brockmann, Jana Godau, Arthur Melms, Thomas Gasser, Stephanie Hörnig, Markus Langkam. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias. Journal of Alzheimer's disease : JAD. vol 26. issue 1. 2012-01-10. PMID:21593566. |
using a newly developed enzyme-linked immunosorbent assay (elisa), we measured levels of igg autoantibodies against neuronal and glial structures in serum and cerebrospinal fluid of a total of 91 subjects (13 pdd, 14 dlb, 11 alzheimer's disease (ad), 11 frontotemporal dementia (ftd), 11 vascular dementia patients (vad), and 31 healthy controls). |
2012-01-10 |
2023-08-12 |
human |
| V Camacho, M Marquié, A Lleó, L Alvés, C Artigas, A Flotats, J Duch, R Blesa, T Gómez-Isla, I Carrió, M Estorc. Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.... vol 55. issue 4. 2012-01-03. PMID:21150861. |
dementia with lewy bodies (dlb) must be distinguished from other types of dementia because of important differences in patient management and outcome. |
2012-01-03 |
2023-08-12 |
Not clear |
| Mie Hirohata, Kenjiro Ono, Akiyoshi Morinaga, Tokuhei Ikeda, Masahito Yamad. Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro α-synuclein fibril formation. Neuroscience letters. vol 491. issue 1. 2011-12-30. PMID:21215793. |
the aggregation of α-synuclein (αs) in the central nervous system (cns) is the hallmark of multiple system atrophy (msa) and lewy body diseases including parkinson's disease (pd) and dementia with lewy bodies (dlb) (α-synucleinopathies). |
2011-12-30 |
2023-08-12 |
Not clear |
| Harriet Quigley, Sean J Colloby, John T O'Brie. PET imaging of brain amyloid in dementia: a review. International journal of geriatric psychiatry. vol 26. issue 10. 2011-12-21. PMID:21905095. |
to review the rapidly expanding literature of amyloid pet imaging with particular attention to pittsburgh compound-b (pib) in alzheimer's disease (ad), dementia with lewy bodies (dlb), fronto-temporal dementia (ftd), mild cognitive impairment (mci) and cognitively normal volunteers. |
2011-12-21 |
2023-08-12 |
human |
| Isidro Ferrer, Ana Gómez, Margarita Carmona, Gema Huesa, Silvia Porta, Miquel Riera-Codina, Marta Biagioli, Stefano Gustincich, Ester As. Neuronal hemoglobin is reduced in Alzheimer's disease, argyrophilic grain disease, Parkinson's disease, and dementia with Lewy bodies. Journal of Alzheimer's disease : JAD. vol 23. issue 3. 2011-12-20. PMID:21157025. |
progressing with these studies, hemoglobin expression has been examined in selected cell population in the brains of alzheimer's disease (ad), argyrophilic grain disease (agd), parkinson's disease (pd) and dementia with lewy bodies (dlb). |
2011-12-20 |
2023-08-12 |
human |
| Sharon Ash, Corey McMillan, Rachel G Gross, Philip Cook, Brianna Morgan, Ashley Boller, Michael Dreyfuss, Andrew Siderowf, Murray Grossma. The organization of narrative discourse in Lewy body spectrum disorder. Brain and language. vol 119. issue 1. 2011-12-16. PMID:21689852. |
narrative discourse is an essential component of day-to-day communication, but little is known about narrative in lewy body spectrum disorder (lbsd), including parkinson's disease (pd), parkinson's disease with dementia (pdd), and dementia with lewy bodies (dlb). |
2011-12-16 |
2023-08-12 |
Not clear |
| John T O'Brien, Alistair Burn. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. Journal of psychopharmacology (Oxford, England). vol 25. issue 8. 2011-12-13. PMID:21088041. |
cholinesterase inhibitors should be used for the treatment of people with lewy body dementias (parkinson's disease dementia and dementia with lewy bodies (dlb)), especially for neuropsychiatric symptoms (a). |
2011-12-13 |
2023-08-12 |
Not clear |
| Laura A Volpicelli-Daley, Kelvin C Luk, Tapan P Patel, Selcuk A Tanik, Dawn M Riddle, Anna Stieber, David F Meaney, John Q Trojanowski, Virginia M-Y Le. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron. vol 72. issue 1. 2011-12-07. PMID:21982369. |
inclusions composed of α-synuclein (α-syn), i.e., lewy bodies (lbs) and lewy neurites (lns), define synucleinopathies including parkinson's disease (pd) and dementia with lewy bodies (dlb). |
2011-12-07 |
2023-08-12 |
Not clear |
| Christoph Laske, Andreas J Fallgatter, Elke Stransky, Katja Hagen, Daniela Berg, Walter Maetzle. Decreased α-synuclein serum levels in patients with Lewy body dementia compared to Alzheimer's disease patients and control subjects. Dementia and geriatric cognitive disorders. vol 31. issue 6. 2011-12-06. PMID:21757905. |
detection and differentiation of neurodegenerative dementias, such as dementia with lewy bodies (dlb) and alzheimer's disease (ad), with blood-based biomarkers would facilitate diagnosis and treatment. |
2011-12-06 |
2023-08-12 |
human |
| Michael J Firbank, Andrew M Blamire, Andrew Teodorczuk, Emma Teper, Dipayan Mitra, John T O'Brie. Diffusion tensor imaging in Alzheimer's disease and dementia with Lewy bodies. Psychiatry research. vol 194. issue 2. 2011-12-06. PMID:21955457. |
fewer studies have investigated dementia with lewy bodies (dlb). |
2011-12-06 |
2023-08-12 |
human |
| Kuniaki Kiuchi, Masayuki Morikawa, Toshiaki Taoka, Soichiro Kitamura, Tomohisa Nagashima, Manabu Makinodan, Keiju Nakagawa, Masami Fukusumi, Katsumi Ikeshita, Makoto Inoue, Kimihiko Kichikawa, Toshifumi Kishimot. White matter changes in dementia with Lewy bodies and Alzheimer's disease: a tractography-based study. Journal of psychiatric research. vol 45. issue 8. 2011-11-29. PMID:21315376. |
dementia with lewy bodies (dlb) and alzheimer's disease (ad) are different types of dementia. |
2011-11-29 |
2023-08-12 |
human |